A carregar...
Ticagrelor – toward more efficient platelet inhibition and beyond
Novel antiplatelet drugs, including ticagrelor, are being successively introduced into the therapy of atherothrombotic conditions due to their superiority over a standard combination of clopidogrel with acetylsalicylic acid in patients with acute coronary syndromes (ACS). A P2Y12 receptor antagonist...
Na minha lista:
| Publicado no: | Ther Clin Risk Manag |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5775739/ https://ncbi.nlm.nih.gov/pubmed/29398917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S152369 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|